Downtowns suddenly have too much of it, our medical system too little.
Health Care + Med Tech
The CEO of Xena Therapies discusses her change in strategy to avoid letting Covid-19 derail her rollout of cool therapy medical devices.
The startup is developing therapies for sleep apnea.
In the aftermath of the death of George Floyd, the Minnetonka health insurer has pledged funds and volunteer hours to the Twin Cities.
CEO says that the company’s financial position “remains strong.”
The Minnesota Nurses Association plans to march to the capital, demanding equipment and higher safety standards.
Mayo Clinic and Allina Health say they’re taking steps to recommence elective health care procedures.
The federal government has postponed its national drug take back day due to the pandemic, but Minneapolis-based Deterra is offering a way to get rid of unwanted medications at home.
It seems no industry is spared from the ripple effects of the Covid-19 pandemic.
The pitch? Free, same-day delivery of medications.
Though demand for ventilators remains high, there’s been a significant downturn in sales of the company’s other products.
Under-the-radar Minnesota company posted $206 million in sales last year.
The new device could be 25 times less expensive to make than standard ventilators.
The state’s hospital trade group has asked for additional federal funds to offset losses caused by Covid-19 preparations.
The medical device maker says a Foxconn plant in Wisconsin will produce a line of smaller, portable ventilators.
Mayo leads efforts in developing convalescent plasma therapy as a treatment for Covid-19.
Independent pharmacies are failing at a catastrophic rate, driving competition down and prices up. Is there a cure?
President Trump orders 3M to ramp up production of face masks. Target promises to pitch in.